Coxsackieviral replication and pathogenicity: lessons from gene modified animal models

Rainer Wessely1

  • 1Deutsches Herzzentrum and 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Lazarettstrasse 36, 80636 Munich, Germany rwessely@dhm.mhn.de

Insights

Low levels of persistent coxsackieviral genomes can cause dilated cardiomyopathy in mice. Type I interferons are crucial for controlling viral replication and survival during coxsackieviral infections.

Area of Science:

  • Virology
  • Cardiology
  • Immunology

Background:

  • Coxsackieviruses are linked to human myocarditis and dilated cardiomyopathy.
  • Animal models, especially gene-targeted mice, are vital for understanding viral heart disease.
  • Viral persistence and host immune responses are key factors in pathogenesis.

Purpose of the Study:

  • To review cell culture and transgenic animal models of coxsackieviral persistence.
  • To investigate the link between persistent viral genomes and cardiac pathology.
  • To elucidate the role of innate immunity, specifically interferon signaling, in coxsackieviral infection.

Main Methods:

  • Utilized cell culture models to study coxsackieviral persistence.
  • Employed transgenic mice to mimic viral persistence and cardiac effects.
  • Examined gene-targeted mice deficient in type I or type II interferon signaling.

Main Results:

  • Low levels of persistent, replication-restricted coxsackieviral genomes induced a cytopathic effect in cardiac myocytes.
  • A transgenic mouse model exhibited a phenotype closely resembling human dilated cardiomyopathy.
  • Type I interferons, but not type II, were essential for controlling early viral replication and survival.

Conclusions:

  • Persistent coxsackieviral genomes, even at low levels, can lead to dilated cardiomyopathy.
  • Transgenic mouse models effectively replicate key features of human dilated cardiomyopathy.
  • Type I interferon signaling is critical for host defense against coxsackieviral infections.